News | February 24, 2022
Cadila Healthcare is now Zydus Lifesciences
Zydus unveils its ‘innovation and care’ centric corporate brand identity
Zydus unveils its ‘innovation and care’ centric corporate brand identity
Collaboration in the industry needs to be institutionalised to drive the growth.
As part of its on-going work to track variants, WHO's Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) discussed the latest evidence on the Omicron variant of concern
Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
Robust pipeline with around 50 projects in clinical development / cardiology portfolio poised for growth with launch products Kerendia (finerenone) and Verquvo (vericiguat)
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials
Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants
Subscribe To Our Newsletter & Stay Updated
